Загрузка...
Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned
Nine out of ten metastatic prostate cancer (PCa) patients will develop osseous metastases. Of these, every second will suffer from skeletal-related events (SRE). SRE are associated with an increased risk for death, which is markedly increased in the presence of pathological fracture. Moreover, healt...
Сохранить в:
| Опубликовано в: : | Dent J (Basel) |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5806937/ https://ncbi.nlm.nih.gov/pubmed/29563470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/dj4030028 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|